Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
1990 | 1 |
1992 | 1 |
2000 | 1 |
2004 | 1 |
2005 | 1 |
2009 | 1 |
2010 | 1 |
2011 | 1 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Mortality in sickle cell patients on hydroxyurea therapy.
Blood. 2005 Jan 15;105(2):545-7. doi: 10.1182/blood-2004-01-0322. Epub 2004 Sep 28.
Blood. 2005.
PMID: 15454485
Free article.
Sickle cell disease telemedicine network for rural outreach.
Woods KF, Johnson JA, Kutlar A, Daitch L, Stachura ME.
Woods KF, et al. Among authors: daitch l.
J Telemed Telecare. 2000;6(5):285-90. doi: 10.1258/1357633001935923.
J Telemed Telecare. 2000.
PMID: 11070590
Item in Clipboard
Acute splenic complications and implications of splenectomy in hemoglobin SC disease.
Subbannan K, Ustun C, Natarajan K, Clair B, Daitch L, Fields S, Kutlar F, Kutlar A.
Subbannan K, et al. Among authors: daitch l.
Eur J Haematol. 2009 Sep;83(3):258-60. doi: 10.1111/j.1600-0609.2009.01270.x. Epub 2009 Apr 20.
Eur J Haematol. 2009.
PMID: 19459924
Item in Clipboard
The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: A 17.5 year follow-up.
Steinberg MH, McCarthy WF, Castro O, Ballas SK, Armstrong FD, Smith W, Ataga K, Swerdlow P, Kutlar A, DeCastro L, Waclawiw MA; Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia and MSH Patients' Follow-Up.
Steinberg MH, et al.
Am J Hematol. 2010 Jun;85(6):403-8. doi: 10.1002/ajh.21699.
Am J Hematol. 2010.
PMID: 20513116
Free PMC article.
Clinical Trial.
Item in Clipboard
Improvements in haemolysis and indicators of erythrocyte survival do not correlate with acute vaso-occlusive crises in patients with sickle cell disease: a phase III randomized, placebo-controlled, double-blind study of the Gardos channel blocker senicapoc (ICA-17043).
Ataga KI, Reid M, Ballas SK, Yasin Z, Bigelow C, James LS, Smith WR, Galacteros F, Kutlar A, Hull JH, Stocker JW; ICA-17043-10 Study Investigators.
Ataga KI, et al.
Br J Haematol. 2011 Apr;153(1):92-104. doi: 10.1111/j.1365-2141.2010.08520.x. Epub 2011 Feb 17.
Br J Haematol. 2011.
PMID: 21323872
Free article.
Clinical Trial.
Item in Clipboard
Tissue-specific expression of allogeneic class II MHC molecules induces neither tissue rejection nor clonal inactivation of alloreactive T cells.
Miller J, Daitch L, Rath S, Selsing E.
Miller J, et al. Among authors: daitch l.
J Immunol. 1990 Jan 1;144(1):334-41.
J Immunol. 1990.
PMID: 2136884
Item in Clipboard
Transcription and recombination of the murine RS element.
Daitch LE, Moore MW, Persiani DM, Durdik JM, Selsing E.
Daitch LE, et al.
J Immunol. 1992 Aug 1;149(3):832-40.
J Immunol. 1992.
PMID: 1634771
Item in Clipboard
Cite
Cite